Seres Therapeutics is a late-clinical-stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human microbiome.
We are an exceptional team of drug development and microbiome experts. Our leadership team, board of directors and scientific advisory board have vast experience in the discovery, development, regulatory approval, and successful commercialization of a wide range of therapeutic products.
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics.
Seres is defined by its extraordinary people, and their passion is what drives us on our mission to help patients.
At Seres, we’re leading the microbiome revolution — and our most revolutionary asset is our team. We’re courageous and deeply collaborative, and above all we’re passionate about the commitment we’ve made to blaze a new trail for the benefit of patients.
We are proud of our achievements thus far — including moving multiple novel therapeutics to the clinic for patients — achievements made possible by our amazing teams across the company.
Just as combinations of bacteria perform challenging biological tasks together, integration of our diverse expertise and insights allows us to drive the microbiome revolution and change the face of medicine for patients in need.